Business Wire

Tishomingo Connect expands fiber network into rural Mississippi with Adtran Mosaic One

Share

News summary: Service provider required scalable fiber access technology to give more underserved customers access to reliable, high-speed internet Adtran’s Mosaic One and 10G fiber access platform enable Tishomingo Connect to scale its network rapidly and efficiently Deployment expands broadband access across rural Mississippi, supporting national efforts to close the digital divide

Adtrantoday announced that Tishomingo Connect, a subsidiary of Tishomingo County Electric Power Association (TCEPA), has deployed its Mosaic One SaaS solution to enhance rural broadband access. Leveraging Adtran’s full suite of fiber-to-the-premises and home networking technologies, Tishomingo Connect is ensuring more households and businesses can benefit from its broadband service. With Adtran’s scalable and programmable fiber access technology, the service provider can maximize its existing network investment as it expands its service area to meet the growing demand for fast and reliable internet in Northeast Mississippi. Adtran’s partner LogicomUSA is also playing a key role in the development and deployment of the new broadband network, providing technical support and ongoing NOC services.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240905594150/en/

Adtran’s technology is helping Tishomingo Connect deliver high-speed broadband to underserved regions of rural Mississippi. (Photo: Business Wire)

“Fiber broadband revitalizes communities and transforms lives by increasing economic activity and enabling access to services such as telehealth. That’s why we’re determined to extend the reach of our fiber network to ensure that more households and businesses in rural areas can enjoy the same high-quality broadband as those in other parts of the state,” said Cody Durham, CEO and GM of Tishomingo Connect. “By deploying Adtran’s fiber broadband technology and harnessing the support offered by its expert team, we’re expanding our network rapidly to give communities the connectivity they deserve. What’s more, with Mosaic One, we can deliver a more efficient, consistent and reliable service for all our members.”

Tishomingo Connect’s strategic investment in Adtran’s high-capacity fiber access platform ensures they can leverage extra capacity as data demand rises. With Adtran’s scalable XGS-PON OLTs and SDX Series optical network terminals, offering up to 10Gbit/s symmetrical data rates, network expansion is seamless and rapid. Additionally, Adtran’s SDG 800 Series service delivery gateways deliver high-speed Wi-Fi 6 performance, guaranteeing robust connectivity for an increasing number of household devices. Mosaic One further empowers Tishomingo Connect with actionable intelligence, enhancing subscriber experience and optimizing operations through a comprehensive view of customer interactions. AI-driven insights enable timely maintenance and reduce service disruptions, improving network reliability and cutting operating costs.

“Adtran is proud to be a partner of Tishomingo Connect as it continues its vital work of bringing fiber broadband to its members living in underserved regions of rural Mississippi,” commented John Scherzinger, GM of Americas sales at Adtran. “We have a deep understanding of the challenges and opportunities involved for electric utilities moving into the fiber broadband space. We also have the expertise, experience and technology to ensure these crucially important high-capacity rural networks are built in the most cost-effective way possible. With our Mosaic One and multigigabit fiber access solutions, Tishomingo has a seamless and cost-effective upgrade path to offering even more capable services in the future.”

“We support the work of electric cooperative subsidiaries like Tishomingo Connect to increase broadband connectivity in regions long overlooked by other service providers. That’s why we’re proud to offer a range of value-added services that ensure more rural subscribers can take advantage of a fast and reliable internet connection,” noted Noah Southerland, CEO of LogicomUSA. “Our technology and comprehensive support services are designed to minimize costs and time without compromising quality. This makes it easier for Tishomingo Connect to deploy and manage its broadband network, and it also means end-users benefit from high-quality connectivity they can always rely on.”

About Adtran

ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.

Published by 
ADTRAN Holdings, Inc. 
www.adtran.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240905594150/en/

Contacts

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release

‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye